Prostate-specific membrane antigen-derived primers in a nested reverse transcription polymerase chain reaction for detecting prostatic cancer cells

Japanese Journal of Cancer Research

Volumn 90, Issue 2, 1999, Pages 233-239

  Saimoto, Atsuya ^a   Saito, Shiro ^a   Murai, Masaru ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diagnosis; Nested RT PCR; Prostate cancer; Prostate specific membrane antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033057127     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00738.x     Document Type: Article

References (18)

1. Horoszewicz, J. S., Kawwinski, E. and Murphy, G. P. Monoclonal antibodies to a new antigenic marker in epithelial cells and serum of prostate cancer patients. Anticancer Res., 7, 927-936 (1987).
2. Lopes, A. D., Davis, W. L., Rosentraus, M. J., Uveges, A. J. and Gilman, S. C. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate antibody 7E11-C5. Cancer Res., 50, 6423-6429 (1990).
3. Israeli, R. S., Powell, T. and Neston, W. D. H. Molecular cloning of complementary DNA encoding a prostate-specific membrane antigen. Cancer Res., 53, 227-230 (1993).
4. Holmes, E. H., Greene, T. G., Tino, W. T., Boynton, A. L., Aldape, H. C., Misrock, S. L. and Murphy, G. P. Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostate carcinoma tumors, and serum from prostate cancer patients. Prostate, 7 (Suppl.), 25-29 (1996).
5. Pinto, J. T., Suffoletto, B. P., Berzin, T. M., Qiao, C.H., Lin, S., Tong, W. P., May, F., Mukherjee, B. and Heston, W. D. W. Prostate-specific membrane antigen, a novel folate hydrolase in human prostate carcinoma cells. Clin. Cancer Res., 2, 1445-1451 (1996).
6. Carter, R. E., Feldman, A. R. and Coyle, J. T. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc. Natl. Acad. Sci. USA, 93, 749-753 (1996).
7. Heston, W. D. W. Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase. Urology, 49, 104-112 (1997).
8. Israeli, R. S., Powell, C. T., Corr, J. G., Fair, W. R. and Heston, W. D. W. Expression of the prostate-specific membrane antigen. Cancer Res., 54, 1807-1811 (1994).
9. Su, S. L., Huang, Ih.-P., Fair, W. R., Powell, C. T. and Heston, W. D. W. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res., 55, 1441-1443 (1995).
10. Israeli, R. S., Miller, W. H., Jr., Su, S. L., Powell, C. T., Fair, W. R., Samadi, D. S., Huryk, R. F., DeBlasio, A., Edwards, E. T., Wise, G. J. and Heston, W. D. W. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostate tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res., 54, 6306-6310 (1994).
11. Loric, S., Dumas, F., Eschwege, P., Blanchet, P., Benoit, G., Jardin, A. and Lacour, B. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. Clin. Chem., 41/12, 1698-1704 (1995).
12. Lintula, S. and Stenman, U. The expression of prostate-specific membrane antigen in peripheral blood leukocyte. J. Urol., 157, 1969-1972 (1997).
13. Cama, C., Olsson, C. A., Raffo, A. J., Perlman, H., Buttyan, R., O'Toole, K. M., McMahon, D., Benson, M. C. and Katz, A. E. Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. J. Urol., 153, 1373-1178 (1995).
14. Moreno, J. G., Croce, C. M., Fischer, R., Monne, M., Vihko, P., Mulholland, S. G. and Gomella, L. G. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52, 6110-6112 (1992).
15. Hamdy, F. C., Lawry, J. B., Anderson, M. A., Parson, R. C., Rees, R. C. and Williams, J. L. Circulating prostate specific antigen positive cells correlate with metastatic prostate cancer. Br. J. Urol. 69, 392-396 (1992).
16. Su, S. L., Heston, D. W., Perrotti, M., Cookson, M. S., Stroubakis, N., Huyrk, R., Edwards, E., Brander, B., Coke, J., Soloway, S., Lewis, A. and Fair, W. R. Evaluating neoadjuvant therapy effectiveness on systemic disease: use of a prostatic-specific membrane reverse transcription polymerase chain reaction. Urology. 49 (Suppl. 3A), 95-101 (1997).
17. Mangold, K. A., Liang, Y., Huey, L. O., Chandler, F. W., Lennox, K., Lewis, R., Allsbrook, W. C., Jr. and Ei-Etreby, F. Enhanced RT-PCR assay for prostate specific antigen (PSA) and prostate specific membrane antigen (PSMA) in peripheral blood: contradictory result. Proc. Am. Assoc. Cancer Res., 38, 526 (1997).
18. Zhang, Y., Zippe, C. D., Van Lente, F., Klein, E. A. and Gupta, M. K. Nested RT-PCR for PSM in detecting hematogenous prostate cancer micrometastases and its role in staging: comparison with PSA. Proc. Am. Assoc. Cancer Res., 38, 526 (1997).